Effect of SR49059, an orally active V1avasopressin receptor antagonist, in the prevention of dysmenorrhoea

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 107, Issue 5, 2000, Pages 614-619

  Brouard, R ^a   Bossmar, T ^c   Fournie Lloret D ^a   Chassard, D ^b   Akerlund M ^c  

^a SANOFI   (France)

^b Aster Clinical Research Center   (France)

^c University Hospital of Lund   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

RELCOVAPTAN; VASOPRESSIN; VASOPRESSIN RECEPTOR ANTAGONIST;

ADULT; ARTICLE; BACKACHE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DYSMENORRHEA; FEMALE; FRANCE; HUMAN; MAJOR CLINICAL STUDY; MENSTRUATION; PELVIS PAIN SYNDROME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPTOMATOLOGY;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DYSMENORRHEA; FEMALE; HUMANS; INDOLES; PAIN MEASUREMENT; PYRROLIDINES; RECEPTORS, VASOPRESSIN; TREATMENT OUTCOME;

EID: 0034052245     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2000.tb13302.x     Document Type: Article

References (18)

1. Åkerlund M, Andersson KE, Ingemarsson I. Effects of terbutaline on myometrial activity, endometrial blood flow and lower abdominal pain in women with primary dysmenorrhoea. Br J Obstet Gynaecol 1976; 83: 673–678.
2. Åkerlund M, Strömberg P, Forsling ML. Primary dysmenorrhoea and vasopressin. Br J Obstet Gynaecol 1979; 86: 484–487.
3. Strömberg P, Åkerlund M, Forsling ML, Granström E, Kindahl H. Vasopressin and prostaglandin in pre-menstrual pain and primary dysmenorrhoea. Acta Obstet Gynecol Scand 1984; 63: 533–538.
4. Ekström P, Laudanski T, Mrugacz G, Forsling M, Kindahl H, Åkerlund M. Stimulation of vasopressin release in women with primary dysmenorrhoea and after oral contraceptive treatment—effect on uterine contractility. Br J Obstet Gynaecol 1992; 99: 680–684.
5. Ekström P, Aim P, Åkerlund M. Differences in vasomotor responses between main stem and smaller branches of the human uterine artery. Acta Obstet Gynecol Scand 1991; 70: 429–433.
6. Bossmar T, Åkerlund M, Fantoni G, Maggi M, Szamatowicz J, Laudanski T. Receptor mediated uterine effects of oxytocin and vasopressin in non-pregnant women. Br J Obstet Gynaecol 1995; 102: 907–912.
7. 1areceptor. J Clin Invest 1994; 92: 224–231.
8. 1avasopressin receptor antagonist, after repeated oral administration in healthy volunteers. Adv Exp Med Biol 1998; 449: 455–465.
9. 1areceptor antagonist, SR49059, and its enantiomer, SR49770, on isolated human myometrium. Acta Obstet Gynecol Scand 1996; 75: 516–519.
10. 1areceptor antagonist, SR49059, on the response of human uterine arteries to vasopressin and other vasoactive substances. Acta Obstet Gynecol Scand 1998; 77: 3–7.
11. 1avasopressin antagonist, on vasopressin-induced uterine contractions. Br J Obstet Gynaecol 1997; 104: 471–477.
12. William EJ. Experimental designs balanced for the residual effects of treatment. Aust J Sci Res 1949; 2:149–168.
13. Sultan C, Sultan N, Jean R. Evaluation clinique quantitative de l'action de la dydrogesterone dans la dysménorrhée de la jeune fille. Gynécologie 1985; 36: 309–315.
14. Higham JM, O'Brien PM, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol 1990; 97: 734–739.
15. Åkerlund M. Can primary dysmenorrhoea be alleviated by a vasopressin antagonist Acta Obstet Gynecol Scand 1987; 66: 459–461.
16. Åkerlund M, Carlsson A-M, Melin P, Trojnar J. The effect on the human uterus of two newly developed competitive inhibitors of oxytocin and vasopressin. Acta Obstet Gynecol Scand 1985; 64: 499–504.
17. Åkerlund M, Brouard R, Bossmar T et al. Receptor binding of oxytocin and vasopressin antagonists and the inhibitory effects on isolated myometrium from preterm and term pregnant women. Br J Obstet Gynaecol 1999; 106: 1047–1053.
18. 1, receptor antagonist, on vasopressin-induced vasoconstriction in humans. Hypertension 1997; 30: 1121–1127.